SIR1-365

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameSIR1-365
Drug Alias NameSIR1-365
ClassificationSmall molecules
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsSystemic Inflammatory Response SyndromeInflammationNeurodegenerative Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPakistanMexico +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSironax Aus Pty Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSironax Aus Pty LtdSironax (Beijing) Co LtdSironax USA Inc
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response SyndromeInflammationNeurodegenerative Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A